What is harm reduction?

It is a public-health strategy that aims to reduce the adverse consequences of a risky behavior without requiring that the behavior stop. It treats the reduction of harm and the reduction of use as separate goals and provides help from wherever a person currently stands (Single, 1995); (Marlatt, 1996).

Does harm reduction mean approving of drug use?

No. It decouples the provision of services from moral approval of the behavior and from a demand for abstinence, but it neither opposes reduced or ended use nor replaces treatment aimed at those goals. It widens the range of acceptable goals so that more people are reached (Ritter & Cameron, 2006); (Hawk et al., 2017).

Why not just require people to stop?

Because most people at any given moment are not ready to stop, and an approach that delivers benefit only upon abstinence reaches only that minority. The transtheoretical model shows change moves through stages, so a strategy that helps at every stage reaches far more people (Prochaska et al., 1992).

How can reducing harm work if the behavior continues?

Expected harm is the product of frequency, per-event risk, and severity. Lowering per-event risk or severity reduces total harm whatever the frequency, and the cuts compound, so a clean needle or a naloxone kit reduces damage even when use is unchanged (Marlatt, 1996).

Does making a behavior safer make it more common?

This is an empirical question answered measure by measure, and for the best-studied measures the answer is no. Evaluations of supervised injection facilities and needle programmes have not found increases in drug use or crime attributable to them (Potier et al., 2014); (Kennedy et al., 2017).

What does the evidence show for specific measures?

Needle and syringe programmes are associated with reduced HIV transmission, opioid substitution treatment with reduced transmission and lower mortality in treatment, supervised injection facilities with reduced overdose death, and naloxone distribution with lower community overdose death rates (Aspinall et al., 2014); (Sordo et al., 2017); (Marshall et al., 2011); (Walley et al., 2013).

What is the risk environment?

It is a framework holding that drug harm emerges from the interaction between individual behavior and the physical, social, economic, and policy conditions surrounding it, so that reducing harm often means changing environments rather than only equipping individuals (Rhodes, 2009); (Collins et al., 2019).

Why do fear-based anti-drug campaigns often fail?

Protection motivation theory predicts that a threat without an accessible, effective response produces avoidance rather than protective action, and risk-perception research shows that people weigh danger by dread and familiarity rather than by probability, so fear appeals misfire where a concrete safer option succeeds (Rogers, 1975); (Slovic, 1987).

Harm Reduction: The Expected-Harm Model

Harm Reduction

Demo 1 · The arithmetic of expected harm

Expected harm is the product of three factors — frequency N, per-event risk p, and severity S. The stylized population injects N = 1,000 times a year at p = 0.002 and S = 0.10, so baseline expected fatal overdoses are H = 0.20. Abstinence lowers N for the few who stop; harm reduction lowers p and S for everyone. The defaults reproduce the article’s worked example. Computed locally, not stored.

Abstinence: share of frequency removed — 10% stop (reaches only them)Harm reduction: cut in per-event risk p — 20% (clean equipment, safer use)Harm reduction: cut in severity S — 70% (naloxone, supervised response)

Baseline H = 1000 × 0.002 × 0.10 = 0.200.
Abstinence acts on N only: 900 × 0.002 × 0.10 = 0.180 — a 10% cut, reaching only the 10% who stop.
Harm reduction acts on p and S for all: 1000 × 0.0016 × 0.030 = 0.048 — a 76% cut. The two cuts compound as 0.24.

Demo 2 · Same facts, opposite choice

A disease threatens 600 people. Two programs are offered. The sure program and the gamble are identical across the two framings — 200 saved is 400 lost, and the gamble’s odds never change. Only the wording moves between a gain frame and a loss frame, yet the majority choice flips. Shares are the classic results reported by Tversky and Kahneman (1981); computed locally, not stored.

200 saved under the sure program400 not saved

Program A: 200 people will be saved.
Program B: a 1-in-3 chance that all 600 are saved, and a 2-in-3 chance that no one is saved.

Typical choice under this frame:

sure 72%

gamble 28%

The gain frame pulls people toward the sure option; the loss frame — describing the very same outcomes as deaths — pushes the majority toward the gamble. Harm-reduction messaging frames a safer practice as a gain to secure rather than a loss to avoid.

Demo 3 · Who the program reaches

The transtheoretical model holds that change moves through stages and that most people are not in the action stage at any one moment. An abstinence-only program delivers benefit only to those in action or maintenance; harm reduction delivers benefit at every stage. Adjust the readiness distribution and watch the reach of each approach. The distribution is illustrative; computed locally, not stored.

PrecontemplationContemplationPreparationActionMaintenance

Abstinence-only reaches the 20% of people in action or maintenance.
Harm reduction reaches 100% — a clean needle or a naloxone kit helps a person in precontemplation who has no intention of stopping, so benefit is delivered across the whole distribution of readiness.

External Links

Harm Reduction (D040261)MeSH descriptorTree F01.145.477 · exactMatch: the descriptor is the article's subject, so the link is carried in about.sameAs.
Harm Reduction (NCBI MeSH)NCBI MeSH term page

Harm Reduction

Demo 1 · The arithmetic of expected harm

Demo 2 · Same facts, opposite choice

Demo 3 · Who the program reaches

Related Topics

External Links